Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYR-472 oral antidiabetic agent trial
jRCT2080221978Phase 3
- Sponsor
- Takeda
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of trelagliptin in diabetes mellitus (DM), sponsored by Takeda.
02
Drugs
trelagliptin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on jRCT2080221978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221978.